Date | Price Target | Rating | Analyst |
---|---|---|---|
12/6/2023 | Mkt Perform | JMP Securities | |
11/3/2023 | $32.00 → $21.00 | Buy → Hold | Jefferies |
6/26/2023 | Outperform | William Blair | |
3/10/2023 | $30.00 | Buy | Loop Capital |
10/5/2022 | $36.00 | Buy → Hold | Truist |
2/24/2022 | $33.00 → $42.00 | Buy | Benchmark |
1/27/2022 | $18.00 → $27.00 | Hold → Buy | Jefferies |
8/16/2021 | $13.50 → $19.00 | Neutral | Credit Suisse |
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) announced today that it is scheduled to participate in two upcoming conferences: The Morgan Stanley 22nd Annual Global Healthcare Conference taking place September 4-6, 2024 at the Marriott Marquis in New York City. John Martins, President & Chief Executive Officer and Josh Vogel, Vice President, Investor Relations, will participate in one-on-one investor meetings on Thursday, September 5. No formal presentation will be made. The 17th Annual Barrington Research Virtual Fall Investment Conference taking place September 12, 2024. William J. Burns, Executive Vice President & Chief Financial Officer and Josh Vogel, Vice Presiden
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its second quarter ended June 30, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q2 2024 vs Q2 2024 vs Dollars are in thousands, except per share amounts Q2 2024 Q2 2023 Q1 2024 Revenue $ 339,771 (37 ) % (10 ) % Gross profit margin* 20.8 % (200 ) bps 40 bps Net (loss) income attributable to common stockh
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wednesday, July 31, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, July 31, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from July 31st through August 14th on the Company's website and a replay of the conferen
Cross Country Healthcare, Inc., (NASDAQ:CCRN), a leading provider of advisory and workforce solutions including contingent staffing, permanent placement, and other consultative services for healthcare clients, has appointed Phillip Noe to the role of Chief Information Officer (CIO). Noe replaces Bill Halnon who is retiring, and will report directly to Kevin C. Clark, Co-founder and CEO. He commences May 10, 2021. "Phil's appointment reflects the ongoing evolution of our digital transformation at Cross Country," said Kevin C. Clark, Co-founder and Chief Executive Officer of Cross Country Healthcare. "His extensive experience in information technology spans every aspect of the software engin
Barrington Research analyst Kevin Steinke maintains Cross Country Healthcare (NASDAQ:CCRN) with a Outperform and lowers the price target from $24 to $21.
Throughout the last three months, 4 analysts have evaluated Cross Country Healthcare (NASDAQ:CCRN), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 1 1 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 1 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.0, a high estimate of $24.00, and a low estimate of $16.00. This current average has decrease
Benchmark analyst Bill Sutherland maintains Cross Country Healthcare (NASDAQ:CCRN) with a Buy and lowers the price target from $21 to $19.
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
4 - CROSS COUNTRY HEALTHCARE INC (0001141103) (Issuer)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
SC 13G/A - CROSS COUNTRY HEALTHCARE INC (0001141103) (Subject)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
10-Q - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
8-K - CROSS COUNTRY HEALTHCARE INC (0001141103) (Filer)
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its second quarter ended June 30, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q2 2024 vs Q2 2024 vs Dollars are in thousands, except per share amounts Q2 2024 Q2 2023 Q1 2024 Revenue $ 339,771 (37 ) % (10 ) % Gross profit margin* 20.8 % (200 ) bps 40 bps Net (loss) income attributable to common stockh
Cross Country Healthcare, Inc. (NASDAQ:CCRN) will hold its quarterly conference call to discuss its second quarter 2024 financial results on Wednesday, July 31, 2024 at 5:00 p.m. Eastern Time. Cross Country Healthcare, Inc. (the "Company") intends to distribute its earnings press release after market close on Wednesday, July 31, 2024. This call will be webcast live and can be accessed at the Company's website at ir.crosscountry.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations – Passcode: Cross Country. A replay of the webcast will be available from July 31st through August 14th on the Company's website and a replay of the conferen
Cross Country Healthcare, Inc. (the "Company") (NASDAQ:CCRN) today announced financial results for its first quarter ended March 31, 2024. SELECTED FINANCIAL INFORMATION: Variance Variance Q1 2024 vs Q1 2024 vs Dollars are in thousands, except per share amounts Q1 2024 Q1 2023 Q4 2023 Revenue $ 379,174 (39) % (8) % Gross profit margin* 20.4 % (200) bps (150) bps Net income attributable to common stockholders $ 2,692 (
JMP Securities initiated coverage of Cross Country with a rating of Mkt Perform
Jefferies downgraded Cross Country from Buy to Hold and set a new price target of $21.00 from $32.00 previously
William Blair initiated coverage of Cross Country with a rating of Outperform